Welcome to our dedicated page for Hyster-Yale SEC filings (Ticker: HY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hyster-Yale, Inc. (NYSE: HY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware-incorporated public company, Hyster-Yale submits current reports on Form 8-K that describe material events such as financial results, restructuring plans, executive officer changes and credit agreements.
Recent 8-K filings include disclosures about quarterly results, where the company reports consolidated revenues, operating profit or loss, segment performance for its lift truck business in the Americas, EMEA and JAPIC, and results for Bolzoni and Nuvera-related activities. Other 8-Ks describe a restructuring plan that reduces the global workforce by approximately 575 employees, the strategic realignment of Nuvera into an integrated energy solutions program, and changes in senior financial leadership.
Hyster-Yale has also filed an 8-K detailing a Third Amended and Restated Loan, Security and Guaranty Agreement that establishes a revolving credit facility with domestic and foreign components, secured by liens on working capital and other assets and subject to covenants on borrowings, dividends and financial ratios. These filings help investors understand the company’s liquidity, leverage and capital structure.
On Stock Titan, AI-powered summaries can help explain the key points in lengthy filings, highlighting items such as restructuring charges, dividend-related disclosures, new credit facilities and management changes. Users can monitor real-time updates from EDGAR, review quarterly earnings-related 8-Ks alongside annual and quarterly reports when available, and examine executive and board changes reported under Item 5.02. This page is a resource for analyzing how Hyster-Yale’s regulatory filings reflect its operating performance, risk factors and strategic decisions in the global materials handling market.
Hyster-Yale, Inc. director reports equity award and indirect holdings
A director of Hyster-Yale, Inc. (HY) reported receiving an award of 1,136 shares of Class A common stock on 01/02/2026. The award was granted at a price of $0 per share as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan and is classified as an acquisition of securities.
Following this transaction, the reporting person shows 23,510 Class A shares held in a trust for the director’s benefit and a large number of additional Class A shares held indirectly through a spouse, children, partnerships, and multiple trusts. Many of these positions arise from derivative holdings in Class B common stock that are shown as convertible into specified amounts of Class A shares. The reporting person disclaims beneficial ownership of all such indirectly held shares.
Hyster-Yale, Inc. reported an insider equity award to a director. A reporting person serving as a director and "other" related role received 1,136 shares of Class A Common Stock on 01/02/2026, recorded as an acquisition at a price of
The report also lists a large number of indirectly held Class A shares in various trusts and limited partnerships connected to family members and estate planning vehicles. For these indirect positions, the reporting person generally serves as trustee, co-trustee, or holds proportionate partnership interests, and expressly disclaims beneficial ownership of all such shares.
Hyster-Yale, Inc. reported that one of its directors received an equity grant under the company’s Non-Employee Directors’ Equity Compensation Plan. On 01/02/2026, the director was awarded 1,136 shares of Class A common stock at a price of $0, recorded as an acquisition of shares rather than a market purchase.
Following this grant, the director beneficially owns 21,587 shares of Hyster-Yale Class A common stock in direct ownership. The award is classified as “Required Shares,” indicating it is part of the standard equity component of non-employee director compensation, with no derivative securities reported in this filing.
Hyster-Yale, Inc. disclosed that a company director received an equity award of 1,136 shares of Class A Common Stock on 01/02/2026. The shares were granted at a price of $0 as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan.
After this grant, the director beneficially owns 15,583 Class A shares, held indirectly in a trust for the reporting person. This filing documents routine equity compensation for board service and does not involve an open-market purchase or sale.
Hyster-Yale, Inc. reported that one of its directors received an equity award of 1,136 shares of Class A common stock on 01/02/2026. The shares were granted at a price of $0 per share as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan. Following this grant, the reporting person beneficially owns 27,321 shares of Class A common stock, held as a direct ownership position.
Hyster-Yale, Inc. director equity grants reported
A director of Hyster-Yale, Inc. reported receiving two stock awards of Class A common stock on 01/02/2026 under the company’s Non-Employee Directors' Equity Compensation Plan. The director was granted 1,136 shares designated as “Required Shares” and 765 shares designated as “Voluntary Shares,” both at a stated price of $0 per share, reflecting equity compensation rather than an open-market purchase. After these awards, the director beneficially owned 8,630 shares of Class A common stock held directly.
Hyster-Yale, Inc. director reported an equity award of Class A Common Stock. On 01/02/2026, the reporting person received 1,136 Class A shares as “Required Shares” under the company’s Non-Employee Directors’ Equity Compensation Plan at a stated price of $0 per share, reflecting a stock grant rather than a purchase.
After this grant, the reporting person is shown with 58,121 Class A shares held in a trust for their benefit, along with extensive additional indirect interests in Class A shares through family trusts, partnerships, and an individual retirement account. The filing states that the reporting person disclaims beneficial ownership of all such indirectly held shares.
Hyster-Yale, Inc. director received a new equity grant in the form of company stock. On 01/02/2026, the reporting person was awarded 1,136 shares of Class A Common Stock at a price of $0 per share. These shares were granted as “Required Shares” under Hyster-Yale’s Non-Employee Directors' Equity Compensation Plan, meaning they represent part of the standard compensation package for board members paid in stock rather than cash.
Following this award, the director beneficially owns 19,819 shares of Hyster-Yale Class A Common Stock in direct ownership. The filing indicates that this is a routine director compensation transaction rather than an open-market purchase or sale.
Hyster-Yale, Inc. director reported a routine stock award. On 01/02/2026, the director received 1,136 shares of Class A common stock at $0 as “Required Shares” under the company’s Non-Employee Directors’ Equity Compensation Plan. These shares are held in a trust for the director’s benefit.
Following this award, the director beneficially owns 7,952 Class A shares indirectly through the trust. The filing reflects standard equity compensation for a non-employee director rather than an open-market trade.
Hyster-Yale, Inc. reports that Senior Vice President, Chief Financial Officer and Treasurer Scott A. Minder has decided to resign, effective December 31, 2025.
The company has begun a search for his successor. During this transition, President and Chief Executive Officer Rajiv K. Prasad will serve as the company’s principal financial officer starting January 1, 2026. The company notes that Mr. Prasad’s background was previously detailed in its March 25, 2025 definitive proxy statement and that he is not a party to any transaction described in Item 404(a) of Regulation S-K involving the company or its subsidiaries.